|
1
|
Wang X, Wang ZS and Wu LQ: Combined
measurements of tumor number and size helps estimate the outcome of
resection of Barcelona clinic liver cancer stage B hepatocellular
carcinoma. Bmc Surg. 16:2016. View Article : Google Scholar
|
|
2
|
Qin SK, Bai YX, Lim HY, Thongprasert S,
Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, et al:
Randomized, multicenter, open-label study of oxaliplatin plus
fluorouracil/leucovorin versus doxorubicin as palliative
chemotherapy in patients with advanced hepatocellular carcinoma
from Asia. J Clin Oncol. 31:3501–3508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
França AV, Elias Junior J, Lima BL,
Martinelli AL and Carrilho FJ: Diagnosis, staging and treatment of
hepatocellular carcinoma. Braz J Med Biol Res. 37:1689–1705. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Fuster J and Bruix J;
Barcelona-Clinic Liver Cancer G, : The Barcelona approach:
Diagnosis, staging, and treatment of hepatocellular carcinoma.
Liver Transpl. 10:S115–S120. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ and
Wu F: Solitary large hepatocellular carcinoma a specific subtype of
hepatocellular carcinoma with good outcome after hepatic resection.
Ann Surg. 249:118–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ochiai T, Sonoyama T, Ichikawa D, Fujiwara
H, Okamoto K, Sakakura C, Ueda Y, Otsuji E, Itoi H, Hagiwara A and
Yamagishi H: Poor prognostic factors of hepatectomy in patients
with resectable small hepatocellular carcinoma and cirrhosis. J
Cancer Res Clin Oncol. 130:197–202. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cong WM and Wu MC: Small hepatocellular
carcinoma: Current and future approaches. Hepatol Int. 7:805–812.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaneko H, Takagi S and Shiba T:
Laparoscopic partial hepatectomy and left lateral segmentectomy:
Technique and results of a clinical series. Surgery. 120:468–475.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seki T, Tamai T, Nakagawa T, Imamura M,
Nishimura A, Yamashiki N, Ikeda K and Inoue K: Combination therapy
with transcatheter arterial chemoembolization and percutaneous
microwave coagulation therapy for hepatocellular carcinoma. Cancer.
89:1245–1251. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shiozawa K, Watanabe M, Wakui N, Ikehara
T, Iida K and Sumino Y: Risk factors for the local recurrence of
hepatocellular carcinoma after single-session percutaneous
radiofrequency ablation with a single electrode insertion. Mol Med
Rep. 2:89–95. 2009.PubMed/NCBI
|
|
11
|
Terzi E, Piscaglia F, Forlani L, Mosconi
C, Renzulli M, Bolondi L and Golfieri R; BLOG-Bologna Liver
Oncology Group, ; S. Orsola-Malpighi Hospital, University of
Bologna, Bologna, Italy, : TACE performed in patients with a single
nodule of hepatocellular carcinoma. BMC Cancer. 14:6012014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang WZ, Jiang N, Huang N, Huang JY, Zheng
QB and Shen Q: Combined therapy with transcatheter arterial
chemoembolization and percutaneous microwave coagulation for small
hepatocellular carcinoma. World J Gastroenterol. 15:748–752. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu CC, Liu NZ, Deng QS, Li XW, Ma KS and
Bie P: Radiofrequency ablation vs. surgical resection on the
treatment of patients with small hepatocellular carcinoma: A system
review and meta-analysis sf five randomized controlled trials.
Hepato-Gastroenterol. 61:1722–1729. 2014.
|
|
14
|
De Carlis L, Giacomom A, Pirotta V,
Lauterio A, Slim AO, Sammartino C, Cardillo M and Forti D: Surgical
treatment of hepatocellular cancer in the era of hepatic
transplantation. J Am Coll Surgeons. 196:887–897. 2003. View Article : Google Scholar
|
|
15
|
Kamo N, Kaido T, Yagi S, Okajima H and
Uemoto S: Liver transplantation for small hepatocellular carcinoma.
Hepatol Surg Nutr. 5:391–398. 2016. View Article : Google Scholar
|
|
16
|
Hsu HC, Wu TT, Wu MZ, Sheu JC, Lee CS and
Chen DS: Tumor invasiveness and prognosis in resected
hepatocellular carcinoma. Clinical and pathogenetic implications.
Cancer. 61:2095–2099. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang G, Lau WY, Wang ZG, Pan ZY, Yuan SX,
Shen F, Zhou WP and Wu MC: Antiviral therapy improves postoperative
survival in patients with hepatocellular carcinoma: A randomized
controlled trial. Ann Surg. 261:56–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ko CJ, Chien SY, Chou CT, Chen LS, Chen ML
and Chen YL: Factors affecting prognosis of small hepatocellular
carcinoma in Taiwanese patients following hepatic resection. Can J
Gastroenterol. 25:485–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimozawa N and Hanazaki K: Longterm
prognosis after hepatic resection for small hepatocellular
carcinoma. J Am Coll Surg. 198:356–365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sugimachi K, Shirabe K, Taketomi A,
Soejima Y, Iguchi T, Takeishi K, Toshima T, Aishima S, Tajima T and
Maehara Y: Prognostic significance of preoperative imaging in
recipients of living donor liver transplantation for hepatocellular
carcinoma. Transplantation. 91:570–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hakamada K, Kimura N, Miura T, Morohashi
H, Ishido K, Nara M, Toyoki Y, Narumi S and Sasaki M:
Des-gamma-carboxy prothrombin as an important prognostic indicator
in patients with small hepatocellular carcinoma. World J
Gastroentero. 14:1370–1377. 2008. View Article : Google Scholar
|
|
22
|
Hernández-Guerra M, Hernández-Camba A,
Turnes J, Ramos LM, Arranz L, Mera J, Crespo J and Quintero E:
Application of the Barcelona clinic liver cancer therapeutic
strategy and impact on survival. United European Gastroenterol J.
3:284–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prajapati HJ and Kim HS: Treatment
algorithm based on the multivariate survival analyses in patients
with advanced hepatocellular carcinoma treated with trans-arterial
chemoembolization. PLoS One. 12:e01707502017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lok AS: Prevention of hepatitis B
virus-related hepatocellular carcinoma. Gastroenterology.
127:S303–S309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC,
Ye SL, Wu ZQ, Fan J, Qin LX and Zheng BH: Experience of 1000
patients who underwent hepatectomy for small hepatocellular
carcinoma. Cancer. 91:1479–1486. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao JH, Zhang H, Wei LS, Xie SP and Suo
ZM: Comparing the long-term efficacy of standard and combined
minimally invasive procedures for unresectable HCC: A mixed
treatment comparison. Oncotarget. 8:15101–15113. 2017.PubMed/NCBI
|
|
27
|
Takuma Y, Takabatake H, Morimoto Y,
Toshikuni N, Kayahara T, Makino Y and Yamamoto H: Comparison of
combined transcatheter arterial chemoembolization and
radiofrequency ablation with surgical resection by using propensity
score matching in patients with hepatocellular carcinoma within
milan criteria. Radiology. 269:927–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Omata M, Lesmana LA, Tateishi R, Chen PJ,
Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, et al: Asian
Pacific Association for the study of the liver consensus
recommendations on hepatocellular carcinoma. Hepatol Int.
4:439–474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Poon RT, Fan ST, Lo CM, Liu CL and Wong J:
Difference in tumor invasiveness in cirrhotic patients with
hepatocellular carcinoma fulfilling the Milan criteria treated by
resection and transplantation: Impact on long-term survival. Ann
Surg. 245:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagashima I, Hamada C, Naruse K, Osada T,
Nagao T, Kawano N and Muto T: Surgical resection for small
hepatocellular carcinoma. Surgery. 119:40–45. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Segawa T, Izawa K, Tsunoda T, Kanematsu T,
Shima M, Matsunaga N and Hayashi K: Evaluation of hepatectomy in
small hepatocellular carcinoma-comparison with transcatheter
arterial embolization therapy. Nihon Geka Gakkai Zasshi.
93:1095–1099. 1992.(In Japanese). PubMed/NCBI
|
|
32
|
Huang J, Yan L, Cheng Z, Wu H, Du L, Wang
J, Xu Y and Zeng Y: A randomized trial comparing radiofrequency
ablation and surgical resection for HCC conforming to the Milan
criteria. Ann Surg. 252:903–912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi J, Sun Q, Wang Y, Jing X, Ding J, Yuan
Q, Ren C, Shan S, Wang Y and Du Z: Comparison of microwave ablation
and surgical resection for treatment of hepatocellular carcinomas
conforming to Milan criteria. J Gastroenterol Hepatol.
29:1500–1507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh
AM, Joh JW, Cho SK, Shin SW, Carriere KC, Ahn JH, et al:
Transarterial chemoembolization versus resection for
intermediate-stage (BCLC B) hepatocellular carcinoma. Clin Mol
Hepatol. 22:250–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boutros C, Somasundar P, Garrean S, Saied
A and Espat NJ: Microwave coagulation therapy for hepatic tumors:
Review of the literature and critical analysis. Surg Oncol.
19:e22–e32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tamai T, Oshige A, Tabu K, Tabu E, Ijyuin
S, Sakae H, Onishi H, Muromachi K, Saisyoji A, Oda K, et al:
Utility of percutaneous radiofrequency ablation alone or combined
with transarterial chemoembolization for early hepatocellular
carcinoma. Oncol Lett. 14:3199–3206. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nomura F, Ohnishi K and Tanabe Y: Clinical
features and prognosis of hepatocellular carcinoma with reference
to serum alpha-fetoprotein levels. Analysis of 606 patients.
Cancer. 64:1700–1707. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Choi D, Lim HK, Rhim H, Kim YS, Yoo BC,
Paik SW, Joh JW and Park CK: Percutaneous radiofrequency ablation
for recurrent hepatocellular carcinoma after hepatectomy: Long-term
results and prognostic factors. Ann Surg Oncol. 14:2319–2329. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Carr BI, Guerra V, Giannini EG, Farinati
F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegnù L, Zoli M,
Borzio F, et al: Low alpha-fetoprotein HCC and the role of GGTP.
Int J Biol Markers. 29:e395–e402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Blank S, Wang Q, Fiel MI, Luan W, Kim KW,
Kadri H, Mandeli J and Hiotis SP: Assessing prognostic significance
of preoperative alpha-fetoprotein in hepatitis B-associated
hepatocellular carcinoma: Normal is not the new normal. Ann Surg
Oncol. 21:986–994. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Terentiev AA and Moldogazieva NT:
Alpha-fetoprotein: A renaissance. Tumour Biol. 34:2075–2091. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Giannini EG, Marenco S, Borgonovo G,
Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo
M, Benvegnù L, Zoli M, et al: Alpha-fetoprotein has no prognostic
role in small hepatocellular carcinoma identified during
surveillance in compensated cirrhosis. Hepatology. 56:1371–1379.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Graham JA, Melancon JK, Shetty K and
Johnson LB: Liver transplantation should be offered to patients
with small solitary hepatocellular carcinoma and a positive serum
alpha fetoprotein rather than resection. Am J Surg. 205:374–380.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bholee AK, Peng K, Zhou Z, Chen J, Xu L,
Zhang Y and Chen M: Radiofrequency ablation combined with
transarterial chemoembolization versus hepatectomy for patients
with hepatocellular carcinoma within Milan criteria: A
retrospective case-control study. Clin Transl Oncol. 19:844–852.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Choi D, Lim HK, Rhim H, Kim YS, Lee WJ,
Paik SW, Koh KC, Lee JH, Choi MS and Yoo BC: Percutaneous
radiofrequency ablation for early-stage hepatocellular carcinoma as
a first-line treatment: Long-term results and prognostic factors in
a large single-institution series. Eur Radiol. 17:684–692. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim BK, Ahn SH, Seong JS, Park JY, Kim DY,
Kim JK, Lee DY, Lee KH and Han KH: Early α-fetoprotein response as
a predictor for clinical outcome after localized concurrent
chemoradiotherapy for advanced hepatocellular carcinoma. Liver Int.
31:369–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Khan MM, Saito S, Takagi S, Ohnishi H,
Izumi H, Sakauchi F, Washio M, Sonoda T, Nagata Y, Asakura S, et
al: Relationship between hepatocellular carcinoma and impaired
glucose tolerance among Japanese. Hepatogastroenterology.
53:742–746. 2006.PubMed/NCBI
|
|
49
|
Singal AK and Ayoola AE: Prevalence and
factors affecting occurrence of type 2 diabetes mellitus in Saudi
patients with chronic liver disease. Saudi J Gastroenterol.
14:118–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
